Clicky

Author name: systems

Mental Wellness Wednesday with UnitedHealthcare: Depression and the pandemic

In honor of May being Mental Wellness Awareness Month, every Wednesday we will be featuring a different discussion with an expert from UnitedHealthcare. Tune in on May 5th for more information about recognizing and coping with depression during the pandemic. Some things that will be covered are the signs of depression, coping skills, and when […]

Mental Wellness Wednesday with UnitedHealthcare: Depression and the pandemic Read More »

Psilocybin Improved Overall Symptoms of Depression

Depression scores did not differ significantly between patients who used psilocybin or escitalopram at 6 weeks. These findings, from a phase 2, double-blind, randomized, controlled trial, were published in the New England Journal of Medicine. Patients (N=59) with long-standing, moderate to severe major depressive disorder were recruited via advertisement in the United Kingdom in 2019.

Psilocybin Improved Overall Symptoms of Depression Read More »

Mental Wellness Wednesday with UnitedHealthcare: Depression and the pandemic

In honor of May being Mental Wellness Awareness Month, every Wednesday we will be featuring a different discussion with an expert from UnitedHealthcare. Tune in on May 5th for more information about recognizing and coping with depression during the pandemic. Some things that will be covered are the signs of depression, coping skills, and when

Mental Wellness Wednesday with UnitedHealthcare: Depression and the pandemic Read More »

Intra-Cellular Therapies Announces FDA Acceptance of CAPLYTA® (lumateperone) sNDAs for the Treatment of Bipolar Depression

NEW YORK, May 03, 2021 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review its supplemental New Drug Applications (sNDAs) for lumateperone, an investigational agent for

Intra-Cellular Therapies Announces FDA Acceptance of CAPLYTA® (lumateperone) sNDAs for the Treatment of Bipolar Depression Read More »

Recognising and treating depression in people with dementia – Health Report

A Canadian review of the evidence on the treatment of depression in people with dementia has found that non drug treatments are often better than medications. Guest: Dr Jennifer Watt Geriatrician, St Michael’s Hospital, Toronto Asst Prof, Dept Medicine, University of Toronto Host: Dr Norman Swan Producer: Diane Dean

Recognising and treating depression in people with dementia – Health Report Read More »

Kevin Love opens up about his struggles with mental health

Subscribe to Posted Up with Chris Haynes Cleveland Cavaliers forward, NBA champion and former UCLA star Kevin Love joins Chris Haynes for a conversation about mental health, basketball and Kevin’s up-and-down journey through both. Love opens up about his longtime struggles with anxiety & depression, what inspired him to speak so candidly about these issues,

Kevin Love opens up about his struggles with mental health Read More »